These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 9591280)
21. Synthesis of novel phenylacetic acid derivatives with halogenated benzyl subunit and evaluation as aldose reductase inhibitors. Rakowitz D; Gmeiner A; Schröder N; Matuszczak B Eur J Pharm Sci; 2006 Feb; 27(2-3):188-93. PubMed ID: 16260125 [TBL] [Abstract][Full Text] [Related]
22. Discovery of [3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrrolo[2,3-b]pyridin-1-yl]acetic acids as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications. Van Zandt MC; Doan B; Sawicki DR; Sredy J; Podjarny AD Bioorg Med Chem Lett; 2009 Apr; 19(7):2006-8. PubMed ID: 19250825 [TBL] [Abstract][Full Text] [Related]
23. Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: Synthesis, activity, partitioning, and molecular modeling. Stefek M; Snirc V; Djoubissie PO; Majekova M; Demopoulos V; Rackova L; Bezakova Z; Karasu C; Carbone V; El-Kabbani O Bioorg Med Chem; 2008 May; 16(9):4908-20. PubMed ID: 18395454 [TBL] [Abstract][Full Text] [Related]
24. Aldose reductase inhibitory effect by tectorigenin derivatives from Viola hondoensis. Moon HI; Jung JC; Lee J Bioorg Med Chem; 2006 Nov; 14(22):7592-4. PubMed ID: 16870454 [TBL] [Abstract][Full Text] [Related]
25. The inhibitory effect on aldose reductase by an extract of Ganoderma lucidum. Fatmawati S; Kurashiki K; Takeno S; Kim YU; Shimizu K; Sato M; Imaizumi K; Takahashi K; Kamiya S; Kaneko S; Kondo R Phytother Res; 2009 Jan; 23(1):28-32. PubMed ID: 19107825 [TBL] [Abstract][Full Text] [Related]
26. Effect of Polygonum hydropiper sulfated flavonoids on lens aldose reductase and related enzymes. Haraguchi H; Ohmi I; Sakai S; Fukuda A; Toihara Y; Fujimoto T; Okamura N; Yagi A J Nat Prod; 1996 Apr; 59(4):443-5. PubMed ID: 8699190 [TBL] [Abstract][Full Text] [Related]
27. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy. Sun W; Oates PJ; Coutcher JB; Gerhardinger C; Lorenzi M Diabetes; 2006 Oct; 55(10):2757-62. PubMed ID: 17003340 [TBL] [Abstract][Full Text] [Related]
28. Probing flexibility and "induced-fit" phenomena in aldose reductase by comparative crystal structure analysis and molecular dynamics simulations. Sotriffer CA; Krämer O; Klebe G Proteins; 2004 Jul; 56(1):52-66. PubMed ID: 15162486 [TBL] [Abstract][Full Text] [Related]
29. On the synthesis of bioisosters of o-benzothiazolyloxybenzoic acids and evaluation as aldose reductase inhibitors. Rakowitz D; Muigg P; Schröder N; Matuszczak B Arch Pharm (Weinheim); 2005 Sep; 338(9):419-26. PubMed ID: 16143958 [TBL] [Abstract][Full Text] [Related]
30. In vitro inhibition of lens aldose reductase by (2-benzyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole-8-yl)-acetic acid in enzyme preparations isolated from diabetic rats. Djoubissie PO; Snirc V; Sotnikova R; Zurova J; Kyselova Z; Skalska S; Gajdosik A; Javorkova V; Vlkovicova J; Vrbjar N; Stefek M Gen Physiol Biophys; 2006 Dec; 25(4):415-25. PubMed ID: 17356233 [TBL] [Abstract][Full Text] [Related]
31. Aldose and aldehyde reductases: structure-function studies on the coenzyme and inhibitor-binding sites. El-Kabbani O; Old SE; Ginell SL; Carper DA Mol Vis; 1999 Sep; 5():20. PubMed ID: 10493777 [TBL] [Abstract][Full Text] [Related]
32. Regulation of lens aldose reductase activity by nitric oxide. Srivastava S; Tammali R; Chandra D; Greer DA; Ramana KV; Bhatnagar A; Srivastava SK Exp Eye Res; 2005 Dec; 81(6):664-72. PubMed ID: 15967436 [TBL] [Abstract][Full Text] [Related]
33. Method for isolating tight-binding inhibitors of rat lens aldose reductase. Sun G; Ma Y; Gao X; König S; Fales HM; Kador PF Exp Eye Res; 2004 Dec; 79(6):919-26. PubMed ID: 15642330 [TBL] [Abstract][Full Text] [Related]
34. Reduced nerve blood flow in diabetic rats: relationship to nitric oxide production and inhibition of aldose reductase. Tomlinson DR; Dewhurst M; Stevens EJ; Omawari N; Carrington AL; Vo PA Diabet Med; 1998 Jul; 15(7):579-85. PubMed ID: 9686698 [TBL] [Abstract][Full Text] [Related]
35. Aldehyde reductase: the role of C-terminal residues in defining substrate and cofactor specificities. Rees-Milton KJ; Jia Z; Green NC; Bhatia M; El-Kabbani O; Flynn TG Arch Biochem Biophys; 1998 Jul; 355(2):137-44. PubMed ID: 9675019 [TBL] [Abstract][Full Text] [Related]
36. The aldose reductase inhibitory capacity of Sorbus domestica fruit extracts depends on their phenolic content and may be useful for the control of diabetic complications. Termentzi A; Alexiou P; Demopoulos VJ; Kokkalou E Pharmazie; 2008 Sep; 63(9):693-6. PubMed ID: 18819524 [TBL] [Abstract][Full Text] [Related]
37. Synthesis of [5-(4-pyrrol-1-yl-benzoyl)-1 H-pyrrol-2-yl)]-acetic acid and in vitro study of its inhibitory activity on aldose reductase enzyme and on protein glycation. Anagnostou C; Nicolaou I; Demopoulos VJ Pharmazie; 2002 Jul; 57(7):435-7. PubMed ID: 12168519 [TBL] [Abstract][Full Text] [Related]
38. [Imidazolidine/thiazolidine-acetate aldose reductase inhibitors]. Fresneau P Ann Pharm Fr; 2000 Dec; 58(6):392-404. PubMed ID: 11148374 [TBL] [Abstract][Full Text] [Related]
39. Sclerotiorin, from Penicillium frequentans, a potent inhibitor of aldose reductase. Chidananda C; Rao LJ; Sattur AP Biotechnol Lett; 2006 Oct; 28(20):1633-6. PubMed ID: 16900332 [TBL] [Abstract][Full Text] [Related]
40. Stereospecific recognition of a spirosuccinimide type aldose reductase inhibitor (AS-3201) by plasma proteins: a significant role of specific binding by serum albumin in the improved potency and stability. Kurono M; Fujii A; Murata M; Fujitani B; Negoro T Biochem Pharmacol; 2006 Jan; 71(3):338-53. PubMed ID: 16324683 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]